When does medmix AG report earnings and what matters for MEDX.SW stock?

Medmix reports on 26 Feb 2026. Investors should watch operating margins, segment revenue, guidance and cash flow. These items will drive short-term moves in MEDX.SW stock and affect dividend sustainability.

What are the key valuation metrics to watch for MEDX.SW stock?

Focus on EPS (currently **-0.14**), price-to-book **~1.10**, price-to-sales **~0.99**, net debt/EBITDA **~3.39x**, and free cash flow per share **1.27 CHF** when assessing MEDX.SW stock.

How does Meyka AI view MEDX.SW stock?

Meyka AI rates MEDX.SW **66.91/100** (Grade B, HOLD). The model highlights solid cash flow but negative EPS and leverage risks. This is informational and not investment advice.

What price moves could follow the earnings release for MEDX.SW stock?

A margin beat or stronger guidance could lift MEDX.SW stock above the 50-day average toward a short-term target near **13.50 CHF**. A weak report could push the stock toward the 200-day average near **10.66 CHF**.

CH Stocks

MEDX.SW medmix AG (SIX) earnings preview 25 Feb 2026: margins and cash flow to watch

ByHuzaifa Zahoor February 25, 2026

MEDX.SW stock trades at CHF 11.40 as investors eye medmix AG’s earnings due 26 Feb 2026. The company reports after the close, and the market is focused on margins, free cash flow and dividend sustainability. Intraday volume is 64,984 versus a 50-day avg of 91,914, showing below-average activity. Key numbers to watch in the report include EPS -0.14, dividend per share 0.50 CHF, and guidance that could move the stock across the SIX market in Switzerland.